Finance

Lists
SDPC:IDX
Millennium Pharmacon Internationl Tbk PT
IDR 200.00
+1.01%
(+2.00) 1D
Oct 30, 11:18:57 AM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SDPC...
Open
IDR 200
High
IDR 200
Low
IDR 185
Mkt. cap
260.03B
Avg. vol.
716.75K
Volume
931.90K
Dividend
1.50%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 8, 2026
P/E ratio
6.17
52-wk high
IDR 228
52-wk low
IDR 135
EPS
IDR 32
Shares outstanding
1.27B
No. of employees
1K
Open
IDR 200
High
IDR 200
Low
IDR 185
Mkt. cap
260.03B
Avg. vol.
716.75K
Volume
931.90K
Dividend
1.50%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 8, 2026
P/E ratio
6.17
52-wk high
IDR 228
52-wk low
IDR 135
EPS
IDR 32
Shares outstanding
1.27B
No. of employees
1K
News stories
From web sources and news partners
About Millennium Pharmacon Internationl Tbk PT
CEO-
Employees1.2K
Founded1952
Headquarters-
SectorHealth care provider
Websitempi-indonesia.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.06T
1.11T
1.02T
1.11T
Cost of goods sold
975.40B
1.00T
930.34B
1.02T
Cost of revenue
975.40B
1.00T
930.34B
1.02T
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.24B
61.14B
58.04B
62.13B
Operating expense
59.42B
71.31B
59.44B
62.19B
Total operating expenses
1.03T
1.07T
989.78B
1.08T
Operating income
24.66B
33.66B
28.19B
32.27B
Other non operating income
-
-
-
-
EBT including unusual items
7.31B
21.04B
13.11B
15.00B
EBT excluding unusual items
7.31B
21.04B
13.11B
15.00B
Income tax expense
3.67B
2.95B
3.00B
5.55B
Effective tax rate
50.18%
14.05%
22.91%
36.97%
Other operating expenses
3.18B
10.17B
1.40B
61.09M
Net income
3.64B
18.08B
10.10B
9.46B
Net profit margin
0.34%
1.63%
0.99%
0.85%
Earnings per share
-
-
-
-
Interest and investment income
41.47M
45.33M
37.63M
59.17M
Interest expense
-17.40B
-12.67B
-15.12B
-17.32B
Net interest expenses
-17.36B
-12.63B
-15.09B
-17.26B
Depreciation and amortization charges
-
-
-
-
EBITDA
27.16B
36.39B
29.93B
33.89B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps